IP Library Granted Patent US 11,191,720
Granted Patent B2
US 11,191,720 · App. 16/257,842 · Granted Dec 7, 2021

Chewing gum with improved delivery of cannabinoids

Inventors: Heidi Ziegler Bruun (Vejle Ost, DK); Dorthe Schackinger Boesen (Vejle, DK); Ane Eriksen (Vejle, DK)
A61K9/0058A61K31/05A61K31/192A61K31/352A61K36/185A61K47/36A61K47/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,191,720
App. No.
16/257,842
Granted
Dec 7, 2021
Kind
B2
Abstract

A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum including water-soluble chewing gum ingredients mixed into water-insoluble gum base, wherein the chewing gum has one or more cannabinoids, and wherein the chewing gum generates saliva and delivers at least 10% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing.

Claims (36)

1. A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum comprising water-soluble chewing gum ingredients mixed into water-insoluble gum base,

wherein the chewing gum comprises one or more cannabinoids, and

wherein the chewing gum generates saliva and delivers at least 10% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing,

wherein the one or more cannabinoids is comprised in the water-soluble chewing gum ingredients mixed into the water-insoluble gum base, and

wherein the one or more cannabinoids comprised in the water-soluble chewing gum ingredients is homogeneously distributed in the water-insoluble gum base,

wherein the one or more cannabinoids comprises cannabidiol (CBD).

2. The chewing gum according claim 1 , wherein the chewing gum delivers at most 50% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing.

3. The chewing gum according to claim 1 , wherein the chewing gum delivers at most 30% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing.

4. The chewing gum according to claim 1 , wherein the amount of the one or more cannabinoids is at least 5 mg.

5. The chewing gum according to claim 1 , wherein delivery of the one or more cannabinoids is measured when chewing 60 chews each minute.

6. The chewing gum according to claim 1 , wherein delivery of the one or more cannabinoids is measured when saliva is not swallowed during the 5 minutes of chewing.

7. The chewing gum according to claim 1 , wherein delivery of the one or more cannabinoids is measured when saliva is collected during and after the 5 minutes of chewing and analyzed for content of the one or more cannabinoids.

8. The chewing gum according to claim 1 , wherein the water-insoluble gum base is a natural gum base comprising natural ingredients.

9. The chewing gum according to claim 1 , wherein the gum base comprises one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base.

10. The chewing gum according to claim 1 , wherein the one or more cannabinoids is further comprised in an outer coating of the extruded chewing gum.

11. The chewing gum according to claim 1 , wherein the one or more cannabinoids is both comprised in the extruded chewing gum and an outer coating of the extruded chewing gum.

12. The chewing gum according to claim 1 , wherein the delivery of the one or more cannabinoids is partly controlled by means of release enhancing ingredients.

13. The chewing gum according to claim 1 , wherein at least 10% by weight of the one or more cannabinoids is present in unbound form.

14. The chewing gum according to claim 1 , wherein the gum base comprises less than 50% of gum base polymers.

15. The chewing gum according to claim 1 , wherein the one or more cannabinoids further comprises one or more cannabinoids selected from the group consisting of cannabidiolic acid (CBDA), cannabidivarin (CBDV), salts and derivatives thereof.

16. The chewing gum according to claim 1 , wherein the one or more cannabinoids further comprises one or more cannabinoids selected from the group consisting of tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), salts and derivatives thereof.

17. The chewing gum according to claim 1 , wherein the one or more cannabinoids further comprises cannabigerol (CBG), or salts and derivatives thereof.

18. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least two cannabinoids.

19. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprised in the water-soluble chewing gum ingredients is present in a pre-mixture with one or more sugar alcohols or saccharose.

20. The chewing gum according to claim 1 , wherein the one or more cannabinoids forms part of a complex with cyclodextrin.

21. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least one phytocannabinoid that forms part of an extract when formulated in the chewing gum.

22. The chewing gum according to claim 1 , wherein the chewing gum further comprises terpenes.

23. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least one isolated cannabinoid.

24. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least one water-soluble cannabinoid.

25. The chewing gum according to claim 1 , wherein the chewing gum comprises a self-emulsifying agent.

26. A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum comprising water-soluble chewing gum ingredients mixed into water-insoluble gum base,

wherein the chewing gum comprises one or more cannabinoids, and

wherein the chewing gum generates saliva and delivers at least 10% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing,

wherein the one or more cannabinoids is comprised in the water-soluble chewing gum ingredients mixed into the water-insoluble gum base, and

wherein the one or more cannabinoids is included in a pre-mixture with one or more sugar alcohols or one or more sugars.

27. A method of alleviating or treating a medical condition comprising administering a chewing gum according to claim 1 .

Assignments (3)
CHANGE OF NAME Recorded Oct 1, 2020
From: MEDCAN PHARMA A/S
To: NORDICCAN A/S
Reel/Frame 053967/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2019
From: BRUUN, HEIDI ZIEGLER; BOESEN, DORTHE SCHACKINGER; ERIKSEN, ANE
To: FERTIN PHARMA A/S
Reel/Frame 048921/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2019
From: FERTIN PHARMA A/S
To: MEDCAN PHARMA A/S
Reel/Frame 048921/0660 →
Continuity (1)
Related Publication 20200237659A1 · Jul 30, 2020
Cited By (1)
US 12,629,332